Hemodilution is common in patients with advanced heart failure

Circulation

Volumn 107, Issue 2, 2003, Pages 226-229

  Androne, Ana Silvia ^a   Katz, Stuart D ^a   Lund, Lars ^a   LaManca, John ^a   Hudaihed, Alhakam ^a   Hryniewicz, Katarzyna ^a   Mancini, Donna M ^a,b  

^a Och Spine at New York Presbyterian Hospitals   (United States)

^b Division of Circulatory Physiology   (United States)

Author keywords

Anemia; Blood volume; Heart failure

Indexed keywords

SERUM ALBUMIN I 131;

ADULT; AGED; ARTICLE; CONGESTIVE HEART FAILURE; CONTROLLED STUDY; DISEASE SEVERITY; ERYTHROCYTE VOLUME; FEMALE; HEMATOCRIT; HEMODILUTION; HUMAN; MAJOR CLINICAL STUDY; MALE; PLASMA VOLUME; PRIORITY JOURNAL; PROGNOSIS;

ANEMIA; COHORT STUDIES; COMORBIDITY; ERYTHROCYTE VOLUME; FEMALE; HEART FAILURE, CONGESTIVE; HEMATOCRIT; HEMODILUTION; HUMANS; MALE; MIDDLE AGED; NEW YORK; PLASMA VOLUME; PREVALENCE; PROGNOSIS; SURVIVAL RATE;

EID: 0037458102     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.CIR.0000052623.16194.80     Document Type: Article

References (17)

1. McClellan W, Flanders W, Langston R, et al. Anemia and renal insufficiency are independent risk factors for death among patients with congestive heart failure admitted to community hospitals: a population based study. J Am Soc Nephrol. 2002;13:1928-1936.
2. Silverberg D, Wexler D, Sheps D, et al. The use of subcutaneous erythropoietin and intravenous iron for the treatment of the anemia of severe, resistant, congestive heart failure improves cardiac and renal function and functional cardiac class and markedly reduces hospitalizations. J Am Coll Cardiol. 2000;35:1737-1744.
3. Horwich T, Fonarow G, Hamilton M, et al. Anemia is associated with worse symptoms, greater impairment in functional capacity and a significant increase in mortality in patients with advanced heart failure. J Am Coll Cardiol. 2002;39:1780-1786.
4. Iverson P, Woldbaek P, Tonnessen T, et al. Decreased hematopoiesis in bone marrow of mice with congestive heart failure. Am J Physiol 2002;282:R166-R172.
5. Herrlin B, Nyquist O, Sylven C. Induction of a reduction in hemoglobin concentration by enalapril in stable, moderate heart failure: a double blind study. Br Heart J. 1991;66:199-205.
6. Anand I, Ferrari R, Kalra G, et al. Edema of cardiac origin. Circulation. 1989;80:299-305.
7. Stevenson L, Perloff J. The limited reliability of physical signs for estimating hemodynamics in chronic heart failure. JAMA. 1989;261:884-888.
8. Feldschuh J, Enson Y. Prediction of the normal blood volume. Circulation. 1977;56:605-612.
9. Messmer K, Sunder-Plassmann L, Hemodilution. Progr Surg. 1974;13:208-245.
10. Chapler C, Cain S. The physiologic reserve in oxygen carrying capacity: studies in experimental hemodilution. Can J Physiol Pharmacol. 1986;64:7-12.
11. Forrester JS, Diamond G, Chatterjee K, et al. Medical therapy of acute myocardial infarction by application of hemodynamic subsets. N Engl J Med. 1976;295:1356-1362.
12. Chakko S, Woska D, Martinez H. Clinical, radiographic and hemodynamic correlations in chronic congestive heart failure: conflicting results may lead to inappropriate care. Am J Med. 1991;90:353-359.
13. Kannel W. Epidemiology and prevention of cardiac failure: Framingham Study Insights. Eur Heart J. 1987;8(suppl F):23-29.
14. Ghali J, Kadaika S, Cooper R, et al. Precipitating factors leading to decompensation of heart failure: traits among urban blacks. Arch Intern Med. 1988;148:2013-2016.
15. Levin A, Thompson CR, Ethier J, et al. Left ventricular mass index increase in early renal disease: impact of decline in hemoglobin. Am J Kid Dis. 1999;34:125-134.
16. Anand I, Chandrashekhar Y, Ferrari R, et al. Pathogenesis of edema in chronic severe anemia. Br Heart J. 1993;70:357-362.
17. Maeda K, Tsutamoto T, Wada A, et al. High levels of plasma brain natriuretic peptide and interleukin-6 after optimized treatment for heart failure are independent risk factors for morbidity and mortality in patients with congestive heart failure. J Am Coll Cardiol. 2000;36:1587-1589.